Prophylactic HIPEC in high-risk colorectal cancer: do we really need a randomized clinical trial to prove a "logical" hypothesis?
- PMID: 33866435
- DOI: 10.1007/s10151-021-02419-6
Prophylactic HIPEC in high-risk colorectal cancer: do we really need a randomized clinical trial to prove a "logical" hypothesis?
References
-
- Pinto A, Eveno C, Pocard M (2017) Update on clinical trials in colorectal cancer peritoneal metastasis. Int J Hyperthermia 33(5):543–547 - DOI
-
- Flood M, Narasimhan V, Waters P, et al. (2020) Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review and discussion of latest controversies. Surgeon
-
- Klaver CEL, Wisselink DD, Punt CJA et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet GastroenterolHepatol 4(10):761–770 - DOI
-
- World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194 - DOI
-
- Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL (2018) Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol 36(1):25–33 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical